Dr. Creech and his colleagues seek to understand the clinical and molecular epidemiology of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). The work of the group focuses on describing the changing dynamics of nasal colonization with CA-MRSA and on how these isolates differ from those that cause invasive staphylococcal disease. In addition, the laboratory studies the adaptive response to infection, focusing on the serum antibody response to critical staphylococcal antigens. Work in the Vanderbilt Vaccine Research Program, where Dr. Creech serves as Associate Director, is directed towards clinical trials of vaccines and therapeutics, including monoclonal antibodies targeting S. aureus, influenza vaccine trials, and malaria vaccines. Clinical investigations in the group are led by Gayle Johnson, RN, Shanda Phillips, RN and others within the Vanderbilt Vaccine Research Program. The laboratory is directed by Ms. Nicki Soper, who has extensive experience in microbiology, molecular epidemiology, and human immunology. Dr. Creech graduated cum laude from Vanderbilt University before attending the University of Tennessee College of Medicine. After graduating with high honors, he joined the pediatric housestaff at Vanderbilt Children's Hospital and was Chief Resident in Pediatrics in 2002. During his pediatric infectious diseases fellowship at Vanderbilt Children's Hospital, Dr. Creech completed the Masters in Public Health degree and became part of the Vanderbilt Clinical Research Scholars (VCRS) Program, a competitive NIH K12 award given to young investigators at VUMC. He joined the faculty in July 2006 as Assistant Professor of Pediatric Infectious Diseases and now serves as Associate Director of the Vaccine Research Program and Co-Director of the Pediatric Infectious Diseases Fellowship. The group can be contacted by email (buddy.creech@vanderbilt.edu) or by phone: 615-343-0332 (VVRP).
The following timeline graph is generated from all co-authored publications.
Featured publications are shown below:No featured affiliations
View all affiliations
1161 21st Avenue South
CCC-5311 MCN
Nashville, TN
USA
6153430332 (p)
6153222733 (f)
MeSH terms are retrieved from PubMed records. Learn more.
Key: MeSH Term Keyword
Antibodies, Neutralizing Bacteriological Techniques Bronchitis Calcitonin Gene-Related Peptide Carrier State Catheterization, Central Venous Compassionate Use Trials Critical Care Exotoxins Genetic Vectors Granulomatous Disease, Chronic Heating Hospitals, Pediatric Humans immunology influenza Injections, Intravenous Malaria Vaccines Membrane Transport Proteins Penicillin-Binding Proteins Reproducibility of Results Sarcoma Skin Skin Diseases, Bacterial Soft Tissue Infections Sports staph Staphylococcus aureus Tennessee vaccines Vancomycin Vascular Neoplasms Wound Healing Young Adult